Discover more from PsyMed Ventures Newsletter
Stanford Psychedelics: Robert Malenka
Business Trip by PsyMed Ventures, a podcast about the business of psychedelics
Welcome back to Business Trip by PsyMed Ventures, a podcast about the business of psychedelics! 🍄
Stanford University is one of the leading universities in psychedelic science, focusing on understanding how psychedelics work in the body. Stanford doesn’t have a dedicated center for psychedelic research, but rather they are taking a multidisciplinary and collaborative approach between departments ranging from psychiatry and anaesthesiology to optogenetics (the use of light to control the activity of neurons).
In this 3-part series, we will explore groundbreaking discoveries via leading Stanford researchers who are revealing the significance of psychedelic science in modern research. We start the series with Robert Malenka.
Robert Malenka is a professor of psychiatry at Stanford University with over three decades of experience in preclinical neuroscience research. His primary focus is on the study of psychoactive drugs, including psychedelics, and their potential therapeutic applications. In addition to his academic role, Malenka is a founder and deputy director of the Wsai Neurosciences Institute at Stanford.
In this episode we discuss:
An overview of Stanford’s approach to psychedelic science
How academics fund their research
The difference in time horizon between universities and companies
Opportunities to commercialize academic research
Once you've finished the episode, we'd love to hear your thoughts! Tweet us at @psymedventures to share your views.
P.S. Do you know someone who would enjoy the Business Trip by PsyMed Ventures podcast? Feel free to share this newsletter by clicking the link below and hitting the ❤️ button on this post to help us reach more people on Substack 🙏
Business Trip by PsyMed Ventures is a podcast about psychedelic startups. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.
Thanks for listening,